Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	3.14B
Revenue (ttm)	582.81M
Net Income (ttm)	81.99M
Shares Out	44.93M
EPS (ttm)	1.80
PE Ratio	38.69
Forward PE	n/a
Dividend	1.75 (2.51%)
Ex-Dividend Date	Jun 26, 2025

Volume	9,000
Average Volume	159,243
Open	69.70
Previous Close	70.10
Day's Range	69.70 - 71.10
52-Week Range	56.60 - 88.30
Beta	-0.12
RSI	47.30
Earnings Date	Nov 11, 2025

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 171
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.